MAnnitol for Blood Pressure Stability in HemoDialysis (MAP-HD)
Phase 2
Recruiting
- Conditions
- Hemodialysis ComplicationHemodynamic Instability
- Interventions
- Drug: 0.9% saline
- First Posted Date
- 2020-06-11
- Last Posted Date
- 2024-02-14
- Lead Sponsor
- Brigham and Women's Hospital
- Target Recruit Count
- 30
- Registration Number
- NCT04428372
- Locations
- 🇺🇸
Brigham and Women's, Boston, Massachusetts, United States
Maintenance Versus Reduction of Immunosuppression for Renal Transplant Patients Hospitalized With COVID-19 Disease
Phase 2
Withdrawn
- Conditions
- Kidney Transplant; ComplicationsImmunosuppressionCOVID
- Interventions
- Other: Maintenance or reduction of immunosuppression
- First Posted Date
- 2020-06-09
- Last Posted Date
- 2022-05-04
- Lead Sponsor
- Brigham and Women's Hospital
- Registration Number
- NCT04420364
SystemIc iNflammation and Microvascular diSease PreventIon in psoRiatic diseasE
Phase 4
Withdrawn
- Conditions
- PsoriasisPsoriatic ArthritisCardiovascular Risk Factor
- Interventions
- First Posted Date
- 2020-06-04
- Last Posted Date
- 2021-07-23
- Lead Sponsor
- Brigham and Women's Hospital
- Registration Number
- NCT04417114
Pilot Study of an Implantable Microdevice for Evaluating Drug Responses in Situ in Prostate Cancer
Phase 1
- Conditions
- Radical ProstatectomyProstate Cancer
- Interventions
- Combination Product: Microdevice
- First Posted Date
- 2020-05-22
- Last Posted Date
- 2023-12-14
- Lead Sponsor
- Brigham and Women's Hospital
- Target Recruit Count
- 35
- Registration Number
- NCT04399876
- Locations
- 🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States
Impact of Antioxidant Juice Intake on Brain Injury and Placental Pathology in Infants With Intrauterine Growth Restriction (IUGR)
Not Applicable
Completed
- Conditions
- Intrauterine Growth Restriction
- Interventions
- Dietary Supplement: Placebo JuiceDietary Supplement: Pomegranate Juice
- First Posted Date
- 2020-05-20
- Last Posted Date
- 2023-07-06
- Lead Sponsor
- Brigham and Women's Hospital
- Target Recruit Count
- 103
- Registration Number
- NCT04394910
- Locations
- 🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States
Lung Irradiation for COVID-19 Pneumonia
Not Applicable
Withdrawn
- Conditions
- SARS-CoV 2
- Interventions
- Radiation: Phase 1Radiation: Phase 2
- First Posted Date
- 2020-05-19
- Last Posted Date
- 2022-02-04
- Lead Sponsor
- Brigham and Women's Hospital
- Registration Number
- NCT04393948
- Locations
- 🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States
Improving Safety of Diagnosis and Therapy in the Inpatient Setting
Not Applicable
Completed
- Conditions
- Leg PainCOPDSoft Tissue InfectionsCoughDyspneaProtein-Calorie MalnutritionDeep Vein ThrombosisConfusionMental Status ChangeBack Pain
- Interventions
- Behavioral: Diagnostic Uncertainty Educational CurriculumBehavioral: Diagnostic TimeoutBehavioral: Patient Diagnostic (Dx) QuestionnaireBehavioral: Enhancements to Epic-integrated Quality & Safety Dashboard
- First Posted Date
- 2020-05-19
- Last Posted Date
- 2022-07-26
- Lead Sponsor
- Brigham and Women's Hospital
- Target Recruit Count
- 700
- Registration Number
- NCT04393909
- Locations
- 🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States
Prevention of Opioid Use Disorder After Surgery
Not Applicable
Active, not recruiting
- Conditions
- Opioid UseOpioid DependenceOpioid-use Disorder
- Interventions
- Behavioral: Discharge Order SetsBehavioral: Pharmacist-Led Discharge Counseling and CommunicationBehavioral: Post-discharge Pain Management Follow-upBehavioral: Patient Engagement Pain Management App
- First Posted Date
- 2020-05-19
- Last Posted Date
- 2023-08-07
- Lead Sponsor
- Brigham and Women's Hospital
- Target Recruit Count
- 204
- Registration Number
- NCT04394559
- Locations
- 🇺🇸
Jeffrey L Schnipper, Boston, Massachusetts, United States
Evaluation of SARS-CoV-2 (COVID-19) Antibody-containing Plasma thErapy
Phase 3
Terminated
- Conditions
- COVIDInfectious Disease
- Interventions
- Biological: High-Titer COVID-19 Convalescent Plasma (HT-CCP)Biological: Standard Plasma (FFP)
- First Posted Date
- 2020-04-24
- Last Posted Date
- 2021-08-13
- Lead Sponsor
- Brigham and Women's Hospital
- Target Recruit Count
- 45
- Registration Number
- NCT04361253
- Locations
- 🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States
Replication of the ONTARGET Antihypertensive Trial in Healthcare Claims Data
- First Posted Date
- 2020-04-21
- Last Posted Date
- 2023-07-27
- Lead Sponsor
- Brigham and Women's Hospital
- Target Recruit Count
- 63744
- Registration Number
- NCT04354350
- Locations
- 🇺🇸
Brigham And Women's Hospital, Boston, Massachusetts, United States
© Copyright 2025. All Rights Reserved by MedPath